Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) Gross Margin (2016 - 2025)

Orthofix Medical's Gross Margin history spans 16 years, with the latest figure at 71.09% for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin fell 1969.0% year-over-year to 71.09%, compared with a TTM value of 69.83% through Dec 2025, down 578.0%, and an annual FY2025 reading of 68.83%, down 417.0% over the prior year.
  • Gross Margin for Q4 2025 was 71.09% at Orthofix Medical, down from 72.23% in the prior quarter.
  • The five-year high for Gross Margin was 130.9% in Q4 2021, with the low at 62.8% in Q1 2025.
  • Average Gross Margin over 5 years is 76.26%, with a median of 72.93% recorded in 2022.
  • Year-over-year, Gross Margin surged 7428bps in 2021 and then plummeted -5794bps in 2022.
  • Tracing OFIX's Gross Margin over 5 years: stood at 130.9% in 2021, then tumbled by -44bps to 72.96% in 2022, then dropped by -7bps to 68.17% in 2023, then soared by 33bps to 90.78% in 2024, then fell by -22bps to 71.09% in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Gross Margin are 71.09% (Q4 2025), 72.23% (Q3 2025), and 72.9% (Q2 2025).